Our work also demonstrated that cancer cells can be sensitized to PI-induced apoptosis when NRF1 is depleted [12], thereby establishing the notion that attenuation of the bounce-back response could improve the efficacy of PI-mediated cancer therapy. This evidence concerns the gene NRF1 and cancer.